Selma Tosun

Prof. Dr. Selma Tosun

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2016 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
ZKZehra Karacaer
Zehra Karacaer
BCBanu Cakir
Banu Cakir
HEHakan Erdem
Hakan Erdem
KUKenan Ugurlu
Kenan Ugurlu
GDGul Durmus
Gul Durmus
NONecati Ormeci
Necati Ormeci
The aim of this study was to assess health-related quality of life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and to study related factors. This multicenter study was carried out between January 01 and April 15, 2015 in Turkey in 57 centers. Adults were enrolled and studied in three groups. Group 1: Inactive HBsAg carriers, Group 2: CHB patients receiving antiviral therapy, Group 3: CHB patients who were neither receiving antiviral therapy nor were inactive HBsAg carriers. Study data was collected by face-to-face interviews using a standardized questionnaire, Short Form-36 (SF-36) and Hepatitis B Quality of Life (HBQOL). Values equivalent to p < 0.05 in analyses were accepted as statistically significant. Four thousand two hundred fifty-seven patients with CHB were included in the study. Two thousand five hundred fifty-nine (60.1 %) of the patients were males. Groups 1, 2 and 3, consisted of 1529 (35.9 %), 1721 (40.4 %) and 1007 (23.7 %) patients, respectively. The highest value of HRQOL was found in inactive HBsAg carriers. We found that total HBQOL score increased when antiviral treatment was used. However, HRQOL of CHB patients varied according to their socio-demographic properties. Regarding total HBQOL score, a higher significant level of HRQOL was determined in inactive HBV patients when matched controls with the associated factors were provided. The HRQOL score of CHB patients was higher than expected and it can be worsen when the disease becomes active. Use of an antiviral therapy can contribute to increasing HRQOL of patients.

22 May 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
STSelma Tosun
Selma Tosun
OAOLGU AYGÜN
OLGU AYGÜN
HÖHülya Özkan Özdemir
Hülya Özkan Özdemir
EKElif Korkmaz
Elif Korkmaz
DÖDurmuş Özdemir
Durmuş Özdemir
Viral Hepatitis is one of the major global health problems, affecting millions of people every year. Limited information is available on the impact of social and economic factors on the prevalence of Hepatitis B virus (HBV) in Turkey. This study, contrary to other studies in the literature, was undertaken with the aim of examining the Majority of the excluded data come from the volunteers. There are medical and the social-economic factors affecting the prevalence of HBV. This research, while taking medical factors as control variables, clarify the social and economic factors affecting the prevalence of HBV by utilising clinical data with the use of the Binary Probit Model (BPM). The BPM estimation is a powerful tool to determine not only the factors but explain also the exact impacts of each factor. The estimations of the BPM shows that economic and social variables such as age, gender, migration, education, awareness, social welfare, occupation are very important factors for determining HBV prevalence. Compared to the youngest population, the 46 to 66+ age group has a higher prevalence of HBV. The male respondents were 5% more likely to develop HBV compared to females. When region-specific differences are taken into account, migrating from the poorest parts of the country such as the eastern and south-eastern regions of Turkey are approximately 16% more likely to be infected. The welfare indicators such as a higher number of rooms in the respondent’s house or flat decreases the probability of having HBV and, relatively higher income groups are less likely to develop HBV compared to labourers. The Self-employed/Business owner/Public sector worker category are approximately 10% less likely to develop HBV. When people are aware of the methods of prevention of HBV, they are 6% less likely to be infected. Previous HBV infection history increases the probability of having HBV again B by 17%. These findings strongly suggest that the impact of social and economic factors on the prevalence of HBV is vital. Any improvements in these factors are likely to reduce prevalence of HBV.

1 February 2018 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
BKBircan Kayaaslan
Bircan Kayaaslan
EAEsragul Akinci
Esragul Akinci
AAAlpay Ari
Alpay Ari
ZTZeliha Kocak Tufan
Zeliha Kocak Tufan
SASaygın Nayman Alpat
Saygın Nayman Alpat
FTFehmi Tabak
Fehmi Tabak

10 November 2021 in Postgraduate Medicine
Verified
Journal Article
Closed access
STSelma Tosun
Selma Tosun
HOHülya Ozkan Ozdemir
Hülya Ozkan Ozdemir
EEEsin Erdogan
Esin Erdogan
SASeniz Akcay
Seniz Akcay
MAMurat Aysin
Murat Aysin
BEBurak Eskut
Burak Eskut
Numerous vaccination studies are conducted to protect against COVID-19 infection, and preclinical and clinical studies are still ongoing worldwide. During this extraordinary period, the necessity t...

15 March 2018 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
ZKZehra Karacaer
Zehra Karacaer
STSelma Tosun
Selma Tosun
ABAyşe Batırel
Ayşe Batırel
SŞSuzan Şahin
Suzan Şahin
İAİrem Altaş
İrem Altaş
FKFatma Yılmaz Karadağ
Fatma Yılmaz Karadağ
Background/Aims: The present study aimed to determine the changes in the epidemiology of hepatitis in recent years in an adult Turkish population. Materials and Methods: Overall, 852 patients with acute viral hepatitis from 17 centers were included in this study. Their sociodemographic characteristics, clinical courses, treatments, and laboratory findings were retrospectively analyzed. Results: The most commonly found microorganisms were the hepatitis B virus (55.2%) and hepatitis A virus (37.6%), and the types of acute viral hepatitis differed significantly according to the age group (p≤0.001). The most frequently reported symptom was fatigue (73.7%), and the most common complications were cholecystitis (0.4%) and fulminant hepatitis (0.4%). The median hospital stay was 9 days (range 1-373). In total, 40.8% patients with acute hepatitis B virus developed immunity. Conclusion: In Turkey, there are significantly large adolescent and adult populations susceptible to acute viral hepatitis. Therefore, larger vaccination programs covering these age groups should be implemented. Cite this article as: Karacaer Z, Tosun S, Batırel A, et al. Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study. Turk J Gastroenterol 2018; 29: 177-82.

16 December 2011 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
HEHakan Erdem
Hakan Erdem
STSuda Tekin-Koruk
Suda Tekin-Koruk
IKIbrahim Koruk
Ibrahim Koruk
DTDerya Tozlu-Keten
Derya Tozlu-Keten
AUAysegul Ulu-Kılıc
Aysegul Ulu-Kılıc
HLHakan Leblebicioglu
Hakan Leblebicioglu
Background: Training of infectious disease (ID) specialists is structured on classical clinical microbiology training in Turkey and ID specialists work as clinical microbiologists at the same time. Hence, this study aimed to determine the clinical skills and knowledge required by clinical microbiologists. Methods: A cross-sectional study was carried out between June 1, 2010 and September 15, 2010 in 32 ID departments in Turkey. Only patients hospitalized and followed up in the ID departments between January-June 2010 who required consultation with other disciplines were included. Results: A total of 605 patients undergoing 1343 consultations were included, with pulmonology, neurology, cardiology, gastroenterology, nephrology, dermatology, haematology, and endocrinology being the most frequent consultation specialties. The consultation patterns were quite similar and were not affected by either the nature of infections or the critical clinical status of ID patients. Conclusions: The results of our study show that certain internal medicine subdisciplines such as pulmonology, neurology and dermatology appear to be the principal clinical requisites in the training of ID specialists, rather than internal medicine as a whole.